Drugs Made In America Acquisition (DMIIU) Financials: Revenue & Earnings
DMIIU$10.29+0.06 +0.59%
$652.87M
Market Cap
—
P/E
—
Forward P/E
—
Score
Drugs Made In America Acquisition (DMIIU) Financials: Revenue & Earnings
DMIIU price $10.29 +0.06 +0.59%
- Ticker
- DMIIU
- Price
- $10.29
- Change
- +0.06 +0.59%
- Market cap ?
- $652.87M
- Beta ?
- 0.06
- Sector
- Financial Services
- Industry
- Shell Companies
Fair value
DMIIU fair value Not meaningful. Price $10.29.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Dividends
Yield —. Payout ratio —. Frequency —.
Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Drugs Made In America Acquisition II Corp. Unit (DMIIU) trades at $10.29, with a market cap of $652.87M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn